CYP26A1 and neuroblastoma: The aim of this study was to measure the effect of R116010 on RA metabolism in a panel of neuroblastoma cell lines, which differ in their ability to upregulate CYP26 isoforms in response to RA, and to evaluate the effects of R116010 on RA metabolism in a neuroblastoma xenograft model.